Thomas Kraits Introduces Revolutionary TruDiagnostic TruAge Epigenetic Tests to European Market

Thomas Kraits is pleased to announce the introduction of TruDiagnostic’s TruAge epigenetic tests to the European market. This milestone makes one of the most scientifically advanced biological age measurement tools readily accessible to individuals and health professionals across Europe.

TruAge testing analyses DNA methylation patterns — changes in the way genes are expressed without altering the underlying DNA sequence — to produce an accurate biological age estimate. This approach is widely considered the gold standard in biological age assessment, offering far greater precision than simple blood biomarker panels or physiological tests.

The TruAge Complete test, developed by TruDiagnostic, evaluates multiple epigenetic clocks including well-validated algorithms such as GrimAge and PhenoAge, providing a comprehensive picture of a person’s biological ageing trajectory. Results can inform lifestyle adjustments, supplementation strategies, and clinical decision-making.

Thomas Kraits is committed to ensuring that European customers benefit from the same advances in longevity science available in other markets. By partnering with TruDiagnostic and facilitating access to these tests, Thomas Kraits continues its mission of empowering individuals with the tools they need to understand and improve their health.